Sohomoy
US Fabry Disease Market: Enzyme Replacement Therapies, Oral Pharmacological Chaperones, and Gene Therapy Solutions Driving Growth
Surging early detection through expanded newborn genetic screening programs, rising clinical awareness of late-onset cardiac and renal manifestations, and continuous biopharmaceutical innovations in next-generation enzyme replacement therapies (ERTs) and gene therapies are driving rapid growth across the US Fabry Disease Market. US Fabry disease treatment solutions—comprising recombinant...
8 Views